LINC01545: A Potential Drug Target for Neurodegenerative Diseases

Target Name: LINC01545

NCBI ID: G724087

LINC01545

Other Name(s): CXorf31 | long intergenic non-protein coding RNA 1545 | Long intergenic non-protein coding RNA 1545

LINC01545: A Potential Drug Target for Neurodegenerative Diseases

LINC01545 (CXorf31) is a protein that is expressed in various tissues of the body, including the brain, heart, lungs, and gastrointestinal tract. It is a member of the superfamily of transmembrane protein (SMP) and is characterized by the presence of a long N-terminal extracellular domain, a transmembrane segment, and a C-terminal intracellular domain.

One of the unique features of LINC01545 is its ability to interact with various signaling pathways, including the TGF-β pathway. This interaction is important for the regulation of cell proliferation, differentiation, and survival.

In addition to its role in cell signaling, LINC01545 has also been shown to play a key role in the regulation of inflammation. It has been shown to participate in the immune response by regulating the production and function of immune cells, as well as modulating the inflammatory response.

These properties make LINC01545 an attractive drug target for researchers looking for new treatments for a variety of diseases. For example, LINC01545 has been shown to be a potential therapeutic for a variety of neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and Huntington's disease.

In addition to its potential therapeutic applications, LINC01545 also has significant potential as a biomarker for disease diagnosis and monitoring. Its expression has been shown to be altered in a variety of diseases, including neurodegenerative diseases, which makes it a potential indicator of disease progression and response to therapeutic interventions.

Overall, LINC01545 is a promising protein for drug development and research into the underlying mechanisms of various diseases. Further studies are needed to fully understand its role in disease and to develop effective treatments.

Protein Name: Long Intergenic Non-protein Coding RNA 1545

The "LINC01545 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC01545 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets